Are you a financial expert?Login
FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
Signup

GRANULES

298.3
+25 (9.15%)
Updated 03:29 03/08 IST

GRANULES Buy or Sell - FrontPage Forums

0 Users have submitted 0 trade ideas of Rs. 0 for GRANULES
Disclaimer
0% Bullish
0% Bearish

GRANULES Buy or Sell - Brokerage Reports

No. of reports in last year
7
No. of analysts
5
Average Consensus Forecast
190.57
Consensus Potential
-54.14%
See GRANULES Share Price Targets >>

GRANULES Ratings

Long term GRANULES rating by FrontPage users
  • ★
    ★
  • ★
    ★
  • ★
    ★
  • ★
    ★
  • ★
    ★
4.8/5 (4 Ratings)
Find answers to all your questions on live GRANULES message board: Is GRANULES buy or sell? Should I buy GRANULES shares? Why are GRANULES shares falling? Should I invest in GRANULES stock?

  1. Home
  2. GRANULES Forum

GRANULES Share Price Discussion

B
babul @soumen-BJkPbopcU
Reputation: -2,030 • Today 4:20 AM
Type
Buy
Instrument
GRANULES
Entry Price
₹291
Price@Trade
₹293.65
Target Price
₹295
Stop Price
₹288
Valid Till
Aug 3, 2020 3:20 AM
Margin
₹291,000 approx for 1000 Qty
Status
Waiting for entry
#GRANULES
Like
Reply
G
Great Eagle Analysis  @greateagleta
Reputation: 4,923 • Jul 29 2:24 AM
Great Eagle Analysis in GRANULES
#GRANULES 7% up granules. Super result. Book ne...
#GRANULES
Granules Hit first target and high made 308. Book 70% and hold rest with cost as sl.
Like
Reply
K
kinjal @243535
Reputation: 37 • Jul 29 8:18 AM
Type
Sell
Instrument
GRANULES
Entry Price
₹283.65
Price@Trade
₹283.65
Target Price
₹210
Stop Price
₹340
Valid Till
Aug 28, 2020 3:20 AM
Margin
₹283.65 approx for 1 Qty
Status
Exited
Exit Price
₹287.55
Net P&L
-₹3.9 (-1.37%)
#GRANULES
Like
Reply (1)
Latest replies
kinjal @243535
•
Jul 30 6:09 AM
Update
Exited
Exit Price
₹287.55
Net P&L
-₹3.9 (-1.37%)
D
Ds Mehta @dsmehta
Reputation: 0 • Jul 28 10:49 AM
Q. Can you suggest granules 29 July2020 high.
Like
Reply (24)
Latest replies
Ds Mehta @dsmehta
•
Jul 29 10:13 AM
More chances up or down
Parveen @parveenB1I8Kxj9r
•
Jul 29 10:15 AM
If short term than down
Parveen @parveenB1I8Kxj9r
•
Jul 29 10:15 AM
Follow stoploss
Ds Mehta @dsmehta
•
Jul 29 10:16 AM
Chart Dekh kar batai
Parveen @parveenB1I8Kxj9r
•
Jul 29 10:17 AM
Yes
T
Trade With Aryan @tradewithoutemot...
Reputation: 13,503 • Jul 28 6:39 AM
Type
Sell
Instrument
GRANULES
Entry Price
₹291.6
Price@Trade
₹291.6
Target Price
₹280.25
Stop Price
₹296.9
Valid Till
Jul 28, 2020 3:20 AM
Margin
₹100,018.8 approx for 343 Qty
Status
Validity Over
Exit Price
₹291.95
Net P&L
-₹120.05 (-0.12%)
#GRANULES
Like
Reply (1)
Latest replies
TrackerBot @trackerbot
•
Jul 28 8:50 AM
Update
Validity Over
Exit Price
₹291.95
Net P&L
-₹120.05 (-0.12%)
T
Trade With Aryan @tradewithoutemot...
Reputation: 13,503 • Jul 28 4:11 AM
Type
Sell
Instrument
GRANULES
Entry Price
₹294.25
Price@Trade
₹294.25
Target Price
₹283
Stop Price
₹299.65
Valid Till
Jul 28, 2020 3:20 AM
Margin
₹100,045 approx for 340 Qty
Status
Validity Over
Exit Price
₹291.95
Net P&L
+₹782 (+0.78%)
#GRANULES
Like
Reply (1)
Latest replies
TrackerBot @trackerbot
•
Jul 28 8:50 AM
Update
Validity Over
Exit Price
₹291.95
Net P&L
+₹782 (+0.78%)
B
babul @soumen-BJkPbopcU
Reputation: -2,030 • Jul 27 6:46 AM
Type
Buy
Instrument
GRANULES
Entry Price
₹300  ₹299
Price@Trade
₹299.5
Target Price
₹310
Stop Price
₹295
Valid Till
Jul 27, 2020 3:20 AM
Margin
₹299,000 approx for 1000 Qty
Status
Stoploss Hit
Exit Price
₹295
Net P&L
-₹4,000 (-1.34%)
#GRANULES
Like
Reply (3)
Latest replies
babul @soumen-BJkPbopcU
•
Jul 27 6:49 AM
Update
Entry Price Modified
Price @ Update
₹299
Original Entry Price
₹300
New Entry Price
₹299
TrackerBot @trackerbot
•
Jul 27 6:50 AM
Update
Trade Entered
Entry Price
₹299
TrackerBot @trackerbot
•
Jul 27 7:56 AM
Update
Stoploss Hit
Exit Price
₹295
N
NewsBot @newsbot
Reputation: 4,625 • Jul 26 1:48 AM
Lupin, Granules India recall around 9.71 lakh bottles of diabetes drug in the US market
As per the USFDA, the companies are recalling the product due to deviation from the current good manufacturing practices (CGMP).
Moneycontrol
Like
Reply
N
NewsBot @newsbot
Reputation: 4,625 • Jul 26 7:53 AM
Lupin, Granules India recall around 9.71 lakh bottles of diabetes drug in the US market
As per the latest Enforcement Report of the US Food and Drug Administration (USFDA), Lupin is recalling 4,92,858 bottles of Metformin Hydrochloride extended-release tablets in 500 mg and 1,000 strengths.
Moneycontrol
Like
Reply
T
The Market Crux @TheMarketCrux
Reputation: 239 • Jul 24 8:51 AM
Like
Reply
C
CS Advisory @samirHkcQyBmzH
Reputation: 1,096 • Jul 24 8:47 AM
Like
Reply
B
babul @soumen-BJkPbopcU
Reputation: -2,030 • Jul 24 3:09 AM
Type
Buy
Instrument
GRANULES
Entry Price
₹282
Price@Trade
₹283
Target Price
₹286
Stop Price
₹280
Valid Till
Jul 24, 2020 3:20 AM
Margin
₹282,000 approx for 1000 Qty
Status
Exited before entry
#GRANULES
Like
Reply (1)
Latest replies
babul @soumen-BJkPbopcU
•
Jul 24 3:17 AM
Update
Exited before entry
Price @ Update
₹285.3
B
babul @soumen-BJkPbopcU
Reputation: -2,030 • Jul 24 2:51 AM
Type
Buy
Instrument
GRANULES
Entry Price
₹283
Price@Trade
₹284.1
Target Price
₹290
Stop Price
₹280  ₹284.3
Valid Till
Jul 24, 2020 3:20 AM
Margin
₹283,000 approx for 1000 Qty
Status
Stoploss Hit
Exit Price
₹284.3
Net P&L
+₹1,300 (+0.46%)
#GRANULES
Like
Reply (4)
Latest replies
babul @soumen-BJkPbopcU
•
Jul 24 3:04 AM
Update
Entry Price Modified
Price @ Update
₹283
Original Entry Price
₹283
New Entry Price
₹283
TrackerBot @trackerbot
•
Jul 24 3:05 AM
Update
Trade Entered
Entry Price
₹283
babul @soumen-BJkPbopcU
•
Jul 24 3:16 AM
Update
Stoploss Trailed
Price @ Update
₹284.4
Original SL
₹280
New SL
₹284.3
TrackerBot @trackerbot
•
Jul 24 3:17 AM
Update
Stoploss Hit
Exit Price
₹284.3
N
NewsBot @newsbot
Reputation: 4,625 • Jul 21 11:43 AM
Buy Granules India; target of Rs 330: Anand Rathi
Anand Rathi recommended hold rating on Granules India with a target price of Rs 330 in its research report dated July 20, 2020.
Moneycontrol
Like
Reply
N
NewsBot @newsbot
Reputation: 4,625 • Jul 21 7:33 AM
Buy Granules India; target of Rs 327: Geojit
Geojit recommended is bullish on Granules India recommended buy rating on the stock with a target price of Rs 327 in its research report dated July 20, 2020.
Moneycontrol
Like
Reply
N
NewsBot @newsbot
Reputation: 4,625 • Jul 21 7:23 AM
Buy Granules India; target of Rs 340: Emkay Global Financial
Emkay Global Financial is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 340 in its research report dated July 17, 2020.
Moneycontrol
Like
Reply
D
DataBot @databot
Reputation: 21,226 • Jul 21 4:00 AM
Geojit Financial Services target on GRANULES
Date: 20-Jul-20 Broker: Geojit Financial Services Price @ Call: 268.01 Target: 327 Recommendation: BUY
#GRANULES
Like
Reply
T
Trade With Aryan @tradewithoutemot...
Reputation: 13,503 • Jul 20 8:08 AM
Type
Sell
Instrument
GRANULES
Entry Price
₹266  ₹264.15
Price@Trade
₹264.75
Target Price
₹245.2
Stop Price
₹273.4
Valid Till
Jul 20, 2020 3:20 AM
Margin
₹99,848.7 approx for 378 Qty
Status
Exited
Exit Price
₹265.3
Net P&L
-₹434.7 (-0.44%)
#GRANULES
Like
Reply (4)
Latest replies
Trade With Aryan @tradewithoutemotions
•
Jul 20 8:38 AM
Update
Entry Price Modified
Price @ Update
₹264
Original Entry Price
₹266
New Entry Price
₹264
Trade With Aryan @tradewithoutemotions
•
Jul 20 8:38 AM
Update
Entry Price Modified
Price @ Update
₹264.15
Original Entry Price
₹264
New Entry Price
₹264.15
TrackerBot @trackerbot
•
Jul 20 8:39 AM
Update
Trade Entered
Entry Price
₹264.15
Trade With Aryan @tradewithoutemotions
•
Jul 20 8:49 AM
Update
Exited
Exit Price
₹265.3
Net P&L
-₹434.7 (-0.44%)
N
NewsBot @newsbot
Reputation: 4,625 • Jul 20 5:58 AM
Buy Granules India ; target of Rs 315: Motilal Oswal
Motilal Oswal is bullish on Granules India recommended buy rating on the stock with a target price of Rs 765 in its research report dated July 18, 2020.
Moneycontrol
Like
Reply
T
Trade With Aryan @tradewithoutemot...
Reputation: 13,503 • Jul 20 5:08 AM
Type
Sell
Instrument
GRANULES
Entry Price
₹268.75
Price@Trade
₹268.75
Target Price
₹252.45
Stop Price
₹275.85
Valid Till
Jul 20, 2020 3:20 AM
Margin
₹100,243.75 approx for 373 Qty
Status
Exited
Exit Price
₹265.25
Net P&L
+₹1,305.5 (+1.3%)
#GRANULES
Like
Reply (1)
Latest replies
Trade With Aryan @tradewithoutemotions
•
Jul 20 8:49 AM
Update
Exited
Exit Price
₹265.25
Net P&L
+₹1,305.5 (+1.3%)
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
Join FrontPage

  • GRANULES - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization2,905.51
    Enterprise Value3,776.07
    Price to Earnings18.9
    Price to Book Value2.04
    Return on Capital Employed0.11
    Return on Equity0.11
    Face Value1
    Dividend Yield0.01

  • GRANULES - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    20-Jul-20Geojit Financial ServicesBuy327
    4-Feb-20Geojit Financial ServicesBuy175
    22-Jan-20Motilal OswalBuy165
    21-Jan-20AnandRathiBuy181
    21-Jan-20CentrumBuy205
    GRANULES Brokerage Price Target

  • GRANULES Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Aug 3274.95304.3274.4299.2
    Jul 31280282.15271.2273.3
    Jul 30282.75292276.15278.6
    Jul 29293294.8281.3282.75
    Jul 28294.15299.7290291.9

  • GRANULES Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹259.56
    30 Day Moving Average₹241.8
    50 Day Moving Average₹220.79
    100 Day Moving Average₹188.61
    200 Day Moving Average₹161.69

  • GRANULES - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue1,6471,349.480.22
    Operating Profit294295.8-0.01
    Profit Before Tax208206.80.01
    Net Income139142.83-0.03

  • GRANULES - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds1,4231,2780.11
    Total Liabilities1,4011,3400.05
    Total Assets2,8242,6180.08

  • GRANULES - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity24197.22-0.88
    Cash from Investing Activity-495-292.750.69
    Cash from Financing Activity52924.220.86
    Net Cash Flow58-71.34-1.81

  • GRANULES - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.050.08
    Return on Equity0.110.16
    Return on Capital Employed0.110.16

  • GRANULES - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.36
    3 Year CAGR Growth in Operating Profit0.4
    3 Year CAGR Growth in EBIDTA0.49
    3 Year CAGR Growth in Net Income0.46
    3 Yr CAGR Growth - Diluted EPS0.18

  • GRANULES - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue1.42
    5 Year CAGR Growth in Operating Profit2.72
    5 Year CAGR Growth in EBIDTA2.92
    5 Year CAGR Growth in Net Income3.61
    3 Yr CAGR Growth - Diluted EPS-0.63

  • GRANULES - Recent News

    keyboard_arrow_down
    NewsBot
    Jul 26 1:48 AM
    Lupin, Granules India recall around 9.71 lakh bottles of diabetes drug in the US market
    Moneycontrol
    NewsBot
    Jul 26 7:53 AM
    Lupin, Granules India recall around 9.71 lakh bottles of diabetes drug in the US market
    Moneycontrol
    NewsBot
    Jul 17 9:11 AM
    Granules India Q1 results: Net profit rises 34% to Rs 111.4 crore - The Economic Times
    The Economic Times
    NewsBot
    Jul 17 1:46 AM
    Board Meetings Today: Britannia, HCL Tech, ICICI Lombard, and Hathway Cable - The Economic Times
    The Economic Times
    NewsBot
    Jun 4 8:11 AM
    Stock Ideas: Anand Rathi has a buy call on Granules India, target price Rs 227
    The Economic Times
    NewsBot
    Apr 28 1:03 AM
    Hot Stocks | Granules India, Dr Lal Path Lab, Navin Flourine are short-term buys
    Moneycontrol
    NewsBot
    Apr 27 6:03 AM
    JB Chemicals, Granules share price up 2-4% on USFDA approval
    Moneycontrol
    NewsBot
    Apr 24 3:43 AM
    Granules India share price rises 6% on USFDA nod
    Moneycontrol
    NewsBot
    Apr 9 7:38 AM
    Granules India gets USFDA approval for Butalbital, Acetaminophen, Caffeine capsules
    Moneycontrol
    NewsBot
    Apr 7 9:13 AM
    Granules India share price gains 12% on EU GMP approval
    Moneycontrol

  • GRANULES - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Apollo Hospitals Enterprise Ltd. NSE:...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.
Privacy•Terms•••
FrontPage © 2020